evidence table
L-Glutamine Gut Health Randomized Trial Evidence Table
Structured evidence table for L-Glutamine Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Glutamine Gut Health Randomized Trial | Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated. | 1 | Zhang Y (2026) | The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials. |
| L-Glutamine Gut Health Randomized Trial | Moreover, immunonutrition reduced the incidence of overall postoperative complications (RR 0.64, 95% CI 0.55, 0.75) and postoperative abdominal distension (RR 0.33, 95% CI 0.12, 0.89). | 1 | Zhang Y (2026) | The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials. |
| L-Glutamine Gut Health Randomized Trial | Conclusion Perioperative immunonutrition supplementation significantly shortened the time to first flatus and time to first defecation after colorectal cancer surgery. | 1 | Zhang Y (2026) | The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials. |
| L-Glutamine Gut Health Randomized Trial | Objective The effect of immunonutrition on postoperative gastrointestinal recovery in patients undergoing colorectal cancer surgery remains controversial. | 1 | Zhang Y (2026) | The effect of immunonutrition on postoperative ileus following colorectal cancer surgery: a systematic review and meta-analysis of randomized controlled trials. |
| L-Glutamine Gut Health Randomized Trial | High-protein diets have dual effects on metabolic dysfunction-associated steatotic liver disease, depending on protein source and amount. | 3 | Yin Hong-Yuan (2026) | High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health |
| L-Glutamine Gut Health Randomized Trial | Patients with metabolic dysfunction-associated steatotic liver disease should favor plant proteins and limit animal proteins; personalized dietary strategies require further mechanistic research. | 3 | Yin Hong-Yuan (2026) | High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health |
| L-Glutamine Gut Health Randomized Trial | 1 2 3 4 1 5 6 7 Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), encompasses a spectrum of liver disorders acquired through metabolic stress[]. | 3 | Yin Hong-Yuan (2026) | High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health |
| L-Glutamine Gut Health Randomized Trial | Plant-based proteins may benefit liver metabolism, inflammation, and gut microbiota, whereas excessive animal proteins could worsen outcomes. | 3 | Yin Hong-Yuan (2026) | High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health |
Source documents